Sohini Das &Amp; Samreen Ahmad

Stories by Sohini Das &Amp; Samreen Ahmad

Mobile user base suffers biggest fall since April 2018

Mobile user base suffers biggest fall since April 2018

Rediff.com   22 May 2019

Mukesh Ambani's Reliance Jio, however, continued to add wireless subscribers

2 reasons why drug sales are in poor health

2 reasons why drug sales are in poor health

Rediff.com   11 May 2019

Overall slowdown in the economy and growing volumes of unbranded generic medicines in the domestic market are behind poor sales.

How Saridon has managed to remain top of the mind

How Saridon has managed to remain top of the mind

Rediff.com   3 May 2019

What has worked though for Brand Saridon has been its single-minded focus on headaches as opposed to other analgesics that dwell on a wider set of problems, reports Sohini Das.

Can Vodafone Idea reap synergy benefits?

Can Vodafone Idea reap synergy benefits?

Rediff.com   23 Apr 2019

India's largest telecom operator in terms of subscriber numbers has been struggling to raise its share of subscribers in the market for fourth-generation technology services.

MNC pharma cos may be afflicted by pneumonia virus

MNC pharma cos may be afflicted by pneumonia virus

Rediff.com   22 Apr 2019

Aurobindo Pharma, Cadila Healthcare and Serum Institute are readying their vaccine candidates.

Why Jio may now have to buy spectrum from the open market

Why Jio may now have to buy spectrum from the open market

Rediff.com   20 Apr 2019

While the company insisted it had enough spectrum across circles, analysts said the company might soon need to acquire some spectrum to ensure uninterrupted service.

Raymond forays into real estate with Thane project

Raymond forays into real estate with Thane project

Rediff.com   4 Apr 2019

The project will house 3,000 residential units across 10 towers in the first phase on a 20-acre land parcel that Raymond owns in Thane

Why cold wave across US is good news for Indian drug cos

Why cold wave across US is good news for Indian drug cos

Rediff.com   12 Mar 2019

Companies such as Cadila Healthcare, Lupin, and Natco, which sell generic versions of flu medication in the US market, are likely to benefit.

Jio likely to grab 51% revenue market share in 3 years

Jio likely to grab 51% revenue market share in 3 years

Rediff.com   7 Jan 2019

Airtel and Vodafone Idea are also trying to expand the penetration of 4G users in their subscriber base as they take this network to the hinterland

Why Google chose this firm for its first Indian start-up investment

Why Google chose this firm for its first Indian start-up investment

Rediff.com   13 Dec 2018

After the Google investment, the company's monthly transactions have spiralled up from 65,000 to nearly one million in just a year. According to reports, the start-up is in fresh talks to raise about $6 million from investors, including Google, says Samreen Ahmad.

Tiger Global back on the prowl in Indian start-up arena

Tiger Global back on the prowl in Indian start-up arena

Rediff.com   6 Dec 2018

The investor has now put together a fund of $3.75 billion to back private companies.

As shares plunge to 5-year low, Sun Pharma promoters poorer by Rs 12,660 crore in 10 days

As shares plunge to 5-year low, Sun Pharma promoters poorer by Rs 12,660 crore in 10 days

Rediff.com   6 Dec 2018

Sun Pharma's market capitalisation stood at Rs 100,050 crore on December 5, with its share price closing at Rs 417 a piece - lowest since March 2013.

Yulu bikes: Pedal your way to beat the traffic

Yulu bikes: Pedal your way to beat the traffic

Rediff.com   5 Dec 2018

Yulu founder Amit Gupta believes bicycle sharing is the next big thing.

The Complete Man shuns online, sticks to physical stores

The Complete Man shuns online, sticks to physical stores

Rediff.com   17 Nov 2018

In this era of online commerce and virtual shopping, Raymond Ltd, one of India's oldest textile manufacturers and retailers, has tailor-made an offline strategy to maintain a strong foothold in the tier III and IV towns. Samreen Ahmad reports.

Bhavdeep Singh, the CEO who championed organ donation quits Fortis

Bhavdeep Singh, the CEO who championed organ donation quits Fortis

Rediff.com   9 Nov 2018

Singh, who was instrumental in building required capabilities in the organisation said his role at Fortis did not allow him to spend time with his family, as the reason behind his resignation.

J&J's loss may be good news for Indian pharmas

J&J's loss may be good news for Indian pharmas

Rediff.com   1 Nov 2018

Dr Reddy's, Glenmark, Wockhardt have lined up alternatives for Zytiga

Swiggy's losses double, but revenue jumps 4-fold

Swiggy's losses double, but revenue jumps 4-fold

Rediff.com   29 Oct 2018

Swiggy had in June entered the elite Unicorn club after raising $210 million from a group of investors

Why drug firms' Q2 revenue growth is likely to dip

Why drug firms' Q2 revenue growth is likely to dip

Rediff.com   12 Oct 2018

Currency played an important role in Q2, with US dollar, Japanese yen and euro appreciating vis-a-vis the Indian rupee, while the Brazilian real, South African rand and Russian ruble depreciating against rupee.

Akshaya Patra takes tech help to better feed 1,761,734 children a day

Akshaya Patra takes tech help to better feed 1,761,734 children a day

Rediff.com   11 Oct 2018

Its newly-built Jigani kitchen in Bengaluru is piloting the use of technologies such as data analytics, blockchain and Internet of Things to speed up the huge volume of its operations while ensuring strict quality control, reports Samreen Ahmad.

Quality perceptions hobble Jan Aushadi drugs

Quality perceptions hobble Jan Aushadi drugs

Rediff.com   10 Oct 2018

Large pharmaceutical firms feel that if the quality parameters and assurance levels are brought up to the level of branded generics, then Jan Aushadhi medicines would find it difficult to retain their affordability.